Conditions: Colorectal Cancer
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 84
Healthy volunteers: no

Brief summary:
Monotherapy treatment with CS-7017 to assess progression-free-survival (PFS) of subjects who achieved an objective response of Disease Control on first line therapy with Folinic acid (leucovorin), Fluorouracil (5-FU), Oxaliplatin (Eloxatin) known as FOLFOX; or Folinic acid (leucovorin), Fluorouracil (5-FU), irinotecan (Camptosar) known as FOLFIRI.

Detailed description:

Arms:
arm 1: None arm 2: Placebo matching CS-7017

Interventions: intervention 1: CS-7017 intervention 2: Placebo
Intervention descriptions: intervention 1: CS-7017 intervention 2: Placebo

Protocol document: